Long noncoding RNAs: Novel prognostic marker in older patients with acute leukemia

Patterns of molecules called long noncoding RNAs might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia, new research shows. AML occurs mainly in older patients and has a three-year survival rate of 5 to 15 percent.

http://ift.tt/1AIKCbP